Skip to main navigation Skip to search Skip to main content

Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women

  • Women's Interagency HIV Study
  • University of California, San Francisco
  • John H. Stroger Jr Hospital of Cook County
  • Georgetown University
  • Yeshiva University
  • USC University of Southern California
  • Johns Hopkins Bloomberg School of Public Health
  • Downstate Medical Center Rheumatology
  • University of California, Davis
  • King's College London
  • Great Ormand Street Institute for Child Health
  • UCL University College London
  • New York University

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Abstract

SORCS2 rs73208473 was recently associated with decreased atazanavir (ATV) concentration in the hair of women with seropositive HIV. Herein, we report on a pharmacogenetic study of women with seropositive HIV demonstrating a similar association between rs73208473 and dose-adjusted plasma ATV concentration in African Americans.
Original languageEnglish
Pages (from-to)315-318
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume107
Issue number2
Early online date28 Sept 2019
DOIs
Publication statusPublished - 1 Feb 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women'. Together they form a unique fingerprint.

Cite this